• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.

作者信息

Hayashi Masachika, Kikuchi Toshiaki, Takada Toshinori

机构信息

Division of Respiratory Medicine, Niigata University Medical and Dental Hospital, 1-754 Asahimachi-dori, Niigata, 951-8520, Japan.

Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, 4132 Urasa, Minami-uonuma, Niigata, 949-7302, Japan.

出版信息

Clin Rheumatol. 2017 Jan;36(1):239-240. doi: 10.1007/s10067-016-3443-2. Epub 2016 Oct 7.

DOI:10.1007/s10067-016-3443-2
PMID:27718019
Abstract
摘要

相似文献

1
Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.霉酚酸酯用于抗MDA - 5抗体阳性无肌病性皮肌炎合并间质性肺疾病的患者。
Clin Rheumatol. 2017 Jan;36(1):239-240. doi: 10.1007/s10067-016-3443-2. Epub 2016 Oct 7.
2
Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis.利妥昔单抗和霉酚酸酯联合成功进行多靶点治疗抗黑色素瘤分化相关基因5抗体阳性且伴有临床无肌病性皮肌炎的快速进展性间质性肺病。
Int J Rheum Dis. 2017 Dec;20(12):2182-2185. doi: 10.1111/1756-185X.13136. Epub 2017 Jul 27.
3
Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.霉酚酸酯治疗临床无肌病性皮肌炎患者的快速进展性间质性肺病。
Mod Rheumatol. 2014 Jul;24(4):694-6. doi: 10.3109/14397595.2013.874762. Epub 2014 Feb 7.
4
A case of anti-MDA5 antibody-positive dermatomyositis developing reversible cerebral vasospasm syndrome successfully treated by multi-immunosuppressant combination including mycophenolate mofetil.抗 MDA5 抗体阳性皮肌炎致可逆性脑血管痉挛综合征 1 例：联合应用吗替麦考酚酯的免疫抑制剂治疗取得成功
Mod Rheumatol Case Rep. 2021 Jan;5(1):69-75. doi: 10.1080/24725625.2020.1810398. Epub 2020 Sep 7.
5
Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis.抗MDA5阳性无肌病性皮肌炎患者的快速进展性间质性肺疾病
Scand J Rheumatol. 2018 Jul;47(4):334-335. doi: 10.1080/03009742.2017.1369155. Epub 2017 Oct 18.
6
[Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].[皮肌炎与MDA-5抗体相关的急性间质性肺病：1例非典型病例]
Ann Dermatol Venereol. 2013 Oct;140(10):628-34. doi: 10.1016/j.annder.2013.04.083. Epub 2013 May 27.
7
A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.一例临床无肌病性皮肌炎伴抗 MDA5 阳性快速进展性间质性肺病患者，在标准免疫抑制治疗的基础上联合利妥昔单抗治疗后病情改善。
Mod Rheumatol. 2017 May;27(3):536-540. doi: 10.3109/14397595.2015.1014140. Epub 2015 Mar 12.
8
The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level.血清铁蛋白水平与无肌病性皮肌炎相关快速进展性间质性肺疾病的治疗反应性相关，与抗MDA5抗体水平无关。
Intern Med. 2018 Feb 1;57(3):387-391. doi: 10.2169/internalmedicine.8335-16. Epub 2017 Nov 1.
9
Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.临床无肌病性皮肌炎（CADM）的诊断与治疗：病例系列报道及文献综述
Clin Rheumatol. 2016 Aug;35(8):2125-2130. doi: 10.1007/s10067-015-2928-8. Epub 2015 Apr 7.
10
Evolution of clinically amyopathic dermatomyositis despite aggressive immunosuppression with cyclophosphamide and prednisone.尽管使用环磷酰胺和泼尼松进行积极免疫抑制治疗，临床无肌病性皮肌炎仍进展。
J Clin Rheumatol. 2010 Apr;16(3):143-5. doi: 10.1097/RHU.0b013e3181d59c59.

引用本文的文献

1
A pilot transcriptomic study of a novel multitargeted BRT regimen for anti-MDA5 antibody-positive dermatomyositis: improving survival over conventional therapy.一项针对抗MDA5抗体阳性皮肌炎的新型多靶点BRT方案的初步转录组学研究：与传统疗法相比提高生存率。
Front Immunol. 2025 Aug 7;16:1568338. doi: 10.3389/fimmu.2025.1568338. eCollection 2025.
2
Successful Treatment with Mycophenolate Mofetil in a Patieint with Anti-MDA 5 Antibody-positive Interstitial Lung Disease and Posterior Reversible Encephalopathy Syndrome.霉酚酸酯成功治疗一名抗MDA 5抗体阳性间质性肺病合并后部可逆性脑病综合征患者
Intern Med. 2025 Jan 1;64(1):113-117. doi: 10.2169/internalmedicine.3533-24. Epub 2024 May 16.
3

本文引用的文献

1
Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.临床无肌病性皮肌炎（CADM）的诊断与治疗：病例系列报道及文献综述
Clin Rheumatol. 2016 Aug;35(8):2125-2130. doi: 10.1007/s10067-015-2928-8. Epub 2015 Apr 7.
2
Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.抗黑色素瘤分化相关基因 5 抗体检测在识别皮肌炎患者和快速进展性间质性肺疾病高危患者中的作用：文献复习和荟萃分析。
Arthritis Care Res (Hoboken). 2013 Aug;65(8):1316-24. doi: 10.1002/acr.21985.
3
Dermatomyositis: Practical Guidance and Unmet Needs.
皮肌炎：实用指南与未满足的需求
Immunotargets Ther. 2024 Mar 6;13:151-172. doi: 10.2147/ITT.S381472. eCollection 2024.
4
Early Initiation of Plasma Exchange Therapy for Anti-MDA5Dermatomyositis with Refractory Rapidly Progressive Interstitial Lung Disease.早期启动血浆置换治疗抗 MDA5 皮肌炎伴难治性快速进展性间质性肺病。
Intern Med. 2024 Jan 15;63(2):213-219. doi: 10.2169/internalmedicine.1410-22. Epub 2023 May 24.
5
Cutaneous Features of Anti-MDA-5 Antibody-Positive Amyopathic Dermatomyositis in a Sudanese Patient.一名苏丹患者抗MDA - 5抗体阳性无肌病性皮肌炎的皮肤特征
Case Rep Dermatol. 2021 Sep 28;13(3):481-485. doi: 10.1159/000519104. eCollection 2021 Sep-Dec.
6
Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management.肌炎相关性间质性肺疾病：诊断与管理的综合方法。
Clin Exp Rheumatol. 2022 Feb;40(2):373-383. doi: 10.55563/clinexprheumatol/brvl1v. Epub 2021 Mar 25.
7
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.霉酚酸酯治疗风湿性疾病相关间质性肺疾病的疗效与安全性：一项叙述性综述
Drugs Context. 2021 Jan 15;10. doi: 10.7573/dic.2020-8-8. eCollection 2021.
8
MDA-5 dermatomyositis complicated by interstitial lung disease and cutaneous ulcers: successful treatment with corticosteroids, mycophenolate mofetil and intravenous immunoglobulin.MDA-5 皮肌炎并发间质性肺病和皮肤溃疡：皮质类固醇、霉酚酸酯和静脉注射免疫球蛋白治疗成功。
BMJ Case Rep. 2020 Sep 30;13(9):e236431. doi: 10.1136/bcr-2020-236431.
9
Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.重新解读类风湿关节炎相关间质性肺疾病的证据以理解其病因。
Curr Rheumatol Rev. 2019;15(4):277-289. doi: 10.2174/1573397115666190116102451.
10
Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.血浆置换成功治疗抗MDA5抗体阳性皮肌炎合并快速进展性间质性肺病：一例报告
Medicine (Baltimore). 2018 Apr;97(15):e0436. doi: 10.1097/MD.0000000000010436.
Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease.
霉酚酸酯可改善结缔组织病相关间质性肺疾病的肺功能。
J Rheumatol. 2013 May;40(5):640-6. doi: 10.3899/jrheum.121043. Epub 2013 Mar 1.
4
Mycophenolate mofetil for interstitial lung disease in dermatomyositis.霉酚酸酯治疗皮肌炎相关性间质性肺病。
Arthritis Care Res (Hoboken). 2010 Oct;62(10):1496-501. doi: 10.1002/acr.20212.
5
Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease.霉酚酸酯对患有结缔组织病相关间质性肺病的患者来说是安全的，耐受性良好，并且能维持肺功能。
Chest. 2006 Jul;130(1):30-6. doi: 10.1378/chest.130.1.30.